# Single Ascending Dose Study of ATH-097 in Healthy Participants

> **NCT07640269** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Atheron Therapeutics, Ltd.** · enrollment: 44 (estimated)

## Conditions studied

- This is a Phase I Study Conducted in Healthy Volunteers

## Interventions

- **DRUG:** ATH-097
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07640269
- **Lead sponsor:** Atheron Therapeutics, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-06
- **Primary completion:** 2026-10-20
- **Final completion:** 2026-10-20
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640269, "Single Ascending Dose Study of ATH-097 in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*